%PDF-1.4
%
75 0 obj
<>
endobj
72 0 obj
<>
endobj
185 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-09T11:43:34Z
2024-03-29T02:14:45-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-29T02:14:45-07:00
application/pdf
Heather
2004-176.jan
uuid:c8850126-1dd1-11b2-0a00-bf0827bd3700
uuid:c8850128-1dd1-11b2-0a00-5b0000000000
endstream
endobj
61 0 obj
<>
endobj
62 0 obj
<>
endobj
76 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 43 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 45 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 47 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 49 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 51 0 R/Type/Page>>
endobj
13 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 53 0 R/Type/Page>>
endobj
32 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 55 0 R/Type/Page>>
endobj
217 0 obj
[222 0 R]
endobj
218 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc -0.03101 Tw 10 0 0 10 53.468 735.6616 Tm
[(this study are unduly influenced by the dif)18 (ferent patient pop-)]TJ
-0.0361 Tw 0 -1.2 TD
[(ulation. )55 (Although the upper and lower GI tract subscales that)]TJ
-0.0293 Tw T*
(we created from the GIQLI were not formally validated, cat-)Tj
0.0719 Tw T*
(egorizing the GIQLI items into these 2 domains does have)Tj
0.20959 Tw T*
(face validity and highlights the need for further detailed)Tj
0.02251 Tw T*
[(study of GI dysfunction among the SSc population. Finally)65 (,)]TJ
0.01759 Tc 0.3573 Tw T*
(although we did find several significant associations)Tj
-0.00011 Tc 0.0719 Tw T*
[(between patients\325)-248 (depression scores and their clinical char-)]TJ
0.1458 Tw T*
[(acteristics, the sample was not lar)18 (ge enough to determine)]TJ
0.1196 Tw T*
(whether all the variables of interest were significant inde-)Tj
0.20261 Tw T*
(pendent predictors. In other words, had the sample been)Tj
0.1804 Tw T*
[(lar)18 (ger)40 (, we would have been able to include more patient)]TJ
0.02499 Tw T*
(characteristics into the final multivariate model.)Tj
0.0195 Tw 1.2 -1.2 Td
(Future work in this area should focus on finding ways to)Tj
0.0168 Tc 0.35809 Tw -1.2 -1.2 Td
[(diminish SSc patients\325)-551 (depressive symptoms, perhaps)]TJ
-0.00011 Tc 0.0367 Tw T*
(through a combination of health education, counseling, and)Tj
0.06351 Tw T*
(antidepressant treatment. Primary care physicians, rheuma-)Tj
0.00369 Tc 0.3712 Tw T*
(tologists, and gastroenterologists should recognize that)Tj
-0.00011 Tc -0.01981 Tw T*
(depression and GI dysfunction among SSc patients are com-)Tj
0.06709 Tw T*
(mon and need to be addressed. Research into interventions)Tj
0.28799 Tw T*
(to improve depressive and gastrointestinal symptoms in)Tj
0.11481 Tw T*
(patients with SSc may lead to improvements in quality of)Tj
0.02499 Tw T*
(life for them.)Tj
/T1_1 1 Tf
0 Tw 0 -2.4 TD
(REFERENCES)Tj
/T1_0 1 Tf
0.02499 Tw 8 0 0 8 60.468 437.6616 Tm
[(1.)-875 (Roca RP)111 (, )18 (W)40 (igley FM, )18 (White B. Depressive symptoms associated)]TJ
1.675 -1.25 Td
[(with scleroderma. )55 (Arthritis Rheum 1996;39:1035-40.)]TJ
-1.675 -1.25 Td
[(2.)-875 (Baubet )18 (T)74 (, Brunet M, Garcia De La Pena-Lefebvre J, et al.)]TJ
1.675 -1.25 Td
[(Psychiatric manifestations of systemic sclerosis [French]. )55 (Ann Med)]TJ
0 -1.25 TD
(Interne 2002;153:237-41.)Tj
-1.675 -1.25 Td
[(3.)-875 (Benrud-Larson LM, Haythornthwaite JA, Heinber)18 (g LJ, et al. )18 (The)]TJ
1.675 -1.25 Td
(impact of pain and symptoms of depression in scleroderma. Pain)Tj
0 Tc 0 Tw T*
(2002;95:267-75.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(4.)-875 (Katon )18 (W)92 (, Sullivan MD. Depression and chronic medical illness. )]TJ
1.675 -1.25 Td
[(J Clin Psychiatry 1990;51 Suppl:3-1)37 (1.)]TJ
-1.675 -1.25 Td
[(5.)-875 (Jones NF)80 (. Sur)18 (gical treatment of the hand in systemic sclerosis. In:)]TJ
1.675 -1.25 Td
(Clements PJ, Furst DE, editors. Systemic sclerosis. Baltimore:)Tj
T*
[(W)40 (illiams and )18 (W)40 (ilkins; 1996:569-80.)]TJ
-1.675 -1.25 Td
[(6.)-875 (Poole JL. Occupational and physical therapy)65 (. In: Clements PJ, Furst)]TJ
1.675 -1.25 Td
[(DE, editors. Systemic sclerosis. Baltimore: )18 (W)40 (illiams and )18 (W)40 (ilkins;)]TJ
0 Tc 0 Tw T*
(1996:581-90.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(7.)-875 (Jiranek GC, Bredfelt JE. Or)18 (gan involvement: gut and hepatic )]TJ
1.675 -1.25 Td
(manifestations. In: Clements PJ, Furst DE, editors. Systemic )Tj
T*
[(sclerosis. Baltimore: )18 (W)40 (illiams and )18 (W)40 (ilkins; 1996:453-82.)]TJ
-1.675 -1.25 Td
[(8.)-875 (Poole JL, Steen )18 (VD. )18 (The use of the Health )55 (Assessment)]TJ
1.675 -1.25 Td
(Questionnaire to determine physical disability in systemic sclerosis.)Tj
T*
(Arthritis Care Res 1991;4:27-31.)Tj
-1.675 -1.25 Td
[(9.)-875 (Roca RP)111 (, )18 (W)40 (igley FM. Psychosocial aspects. In: Clements PJ, Furst)]TJ
1.675 -1.25 Td
[(DE, editors. Systemic sclerosis. Baltimore: )18 (W)40 (illiams and )18 (W)40 (ilkins;)]TJ
0 Tc 0 Tw T*
[(1996:501-1)37 (1.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(10.)-875 (Malcarne )18 (VL, Greenber)18 (gs HL. Psychological adjustment to )]TJ
2.175 -1.25 Td
[(systemic sclerosis. )55 (Arthritis Care Res 1996;9:51-9.)]TJ
-2.1381 -1.25 Td
[(1)37 (1.)-875 (W)80 (estbrook MT)74 (, Gething LBB. Belief in ability to control chronic)]TJ
2.1381 -1.25 Td
[(illness: associated evaluations and medical experiences. )55 (Aust)]TJ
0 Tc T*
(Psychol 1987;22:203-18.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(12.)-875 (Moser DK, Clements PJ, Brecht ML, )18 (W)80 (einer SR. Predictors of )]TJ
2.175 -1.25 Td
[(psychosocial adjustment in systemic sclerosis. )18 (The influence of )]TJ
T*
[(formal education level, functional ability)65 (, hardiness, uncertainty)65 (,)]TJ
T*
[(and social support. )55 (Arthritis Rheum 1993;36:1398-405.)]TJ
30.825 78.671 Td
[(13.)-875 (Bur)18 (g MM, )55 (Abrams D. Depression in chronic medical illness: the)]TJ
2.175 -1.25 Td
(case of coronary heart disease. J Clin Psychol 2001;57:1323-37.)Tj
-2.175 -1.25 Td
[(14.)-875 (Ramasubbu R, Patten SB. Ef)18 (fect of depression on stroke morbidity)]TJ
2.175 -1.25 Td
[(and mortality)65 (. Can J Psychiatry 2003;48:250-7.)]TJ
-2.175 -1.25 Td
[(15.)-875 (Carney RM, Freedland KE, Miller GE, Jaf)18 (fe )55 (AS. Depression as a)]TJ
2.175 -1.25 Td
(risk factor for cardiac mortality and morbidity: a review of poten-)Tj
T*
(tial mechanisms. J Psychosom Res 2002;53:897-902.)Tj
-2.175 -1.25 Td
[(16.)-875 (Geerlings SW)92 (, Beekman )55 (A)111 (T)74 (, Deeg DJ, )18 (T)70 (wisk JW)92 (, )18 (V)111 (an )18 (T)35 (ilbur)18 (g )18 (W)92 (.)]TJ
2.175 -1.25 Td
[(The longitudinal ef)18 (fect of depression on functional limitations and)]TJ
T*
(disability in older adults: an eight-wave prospective )Tj
0 Tc T*
[(community-based study)65 (. Psychol Med 2001;31:1361-71.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(17.)-875 (Judd LL, Paulus MP)111 (, )18 (W)80 (ells KB, Rapaport MH. Socioeconomic )]TJ
2.175 -1.25 Td
(burden of subsyndromal depressive symptoms and major )Tj
T*
[(depression in a sample of the general population. )55 (Am J Psychiatry)]TJ
0 Tc 0 Tw T*
[(1996;153:141)37 (1-7.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(18.)-875 (Straszecka J, Kucharz EJ, Jonderko G, et al. Depression and anxi-)]TJ
2.175 -1.25 Td
(ety in patients with systemic sclerosis [letter]. Clin Rheumatol)Tj
0 Tc 0 Tw T*
(1996;15:621.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(19.)-875 (Peveler R, Carson )55 (A, Rodin G. Depression in medical patients.)]TJ
0 Tc 2.175 -1.25 Td
(BMJ 2002;325:149-52.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(20.)-875 (W)80 (eissman MM, Sholomskas D, Pottenger M, Prusof)18 (f BA, Locke)]TJ
2.175 -1.25 Td
[(BZ. )55 (Assessing depressive symptoms in five psychiatric populations:)]TJ
T*
[(a validation study)65 (. )55 (Am J Epidemiol 1977;106:203-14.)]TJ
-2.175 -1.25 Td
[(21.)-875 (Steen )18 (VD, Medsger )18 (T)80 (A)-220 (Jr)55 (. )18 (The value of the Health )55 (Assessment)]TJ
2.175 -1.25 Td
(Questionnaire and special patient-generated scales to demonstrate)Tj
T*
[(change in systemic sclerosis patients over time. )55 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1997;40:1984-91.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(22.)-875 (Clements PJ, )18 (W)80 (ong )18 (WK, Hurwitz EL, et al. Correlates of the )]TJ
2.175 -1.25 Td
[(disability index of the Health )55 (Assessment Questionnaire: a measure)]TJ
T*
[(of functional impairment in systemic sclerosis. )55 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1999;42:2372-80.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(23.)-875 (Eypasch E, )18 (W)40 (illiams JI, )18 (W)80 (ood-Dauphinee S, et al. Gastrointestinal)]TJ
2.175 -1.25 Td
(Quality of Life Index: development, validation and application of a)Tj
T*
[(new instrument. Br J Sur)18 (g 1995;82:216-22.)]TJ
-2.175 -1.25 Td
[(24.)-875 (Masi )55 (A)111 (T)74 (, Rodnan GP)111 (, Medsger )18 (T)80 (A)-220 (Jr)40 (, et al. Subcommittee for)]TJ
2.175 -1.25 Td
[(Scleroderma Criteria of the )55 (American Rheumatism )55 (Association)]TJ
T*
[(Diagnostic )18 (Therapeutic Criteria Committee. Preliminary criteria for)]TJ
T*
[(the classification of systemic sclerosis \(scleroderma\). )55 (Arthritis)]TJ
0 Tc T*
(Rheum 1980;23:581-90.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(25.)-875 (Bobo JK, McIlvain HE, Leed-Kelly )55 (A. Depression screening scores)]TJ
2.175 -1.25 Td
(during residential drug treatment and risk of drug use after )Tj
T*
[(dischar)18 (ge. Psychiatr Serv 1998;49:693-5.)]TJ
-2.175 -1.25 Td
[(26.)-875 (Fries JF)80 (, Spitz PW)92 (, )37 (Y)100 (oung DY)129 (. )18 (The dimensions of health outcomes:)]TJ
2.175 -1.25 Td
[(the Health )55 (Assessment Questionnaire, disability and pain scales. )]TJ
T*
(J Rheumatol 1982;9:789-93.)Tj
-2.175 -1.25 Td
[(27.)-875 (Harrell FE, Lee KL, Mark DB. Multivariable prognostic models:)]TJ
2.175 -1.25 Td
[(issues in developing models, evaluating assumptions and adequacy)65 (,)]TJ
T*
(and measuring and reducing errors. Stat Med 1996;15:361-87.)Tj
-2.175 -1.25 Td
[(28.)-875 (Martens MP)111 (, Parker JC, Smarr KL, Hewett JE, Slaughter JR,)]TJ
2.175 -1.25 Td
[(W)80 (alker SE. )55 (Assessment of depression in rheumatoid arthritis: a)]TJ
T*
(modified version of the Center for Epidemiologic Studies)Tj
T*
[(Depression Scale. )55 (Arthritis Rheum 2003;49:549-55.)]TJ
-2.175 -1.25 Td
[(29.)-875 (Benjamin S, Morris S, McBeth J, Macfarlane GJ, Silman )55 (AJ. )18 (The)]TJ
2.175 -1.25 Td
(association between chronic widespread pain and mental disorder: a)Tj
T*
[(population-based study)65 (. )55 (Arthritis Rheum 2000;43:561-7.)]TJ
-2.175 -1.25 Td
[(30.)-875 (V)111 (an Mof)18 (faert MM. Sleep disorders and depression: the \324chicken)]TJ
2.175 -1.25 Td
[(and egg\325)-201 (situation. J Psychosom Res 1994;38 Suppl 1:9-13.)]TJ
-2.175 -1.25 Td
[(31.)-875 (Krishnan KR. Depression as a contributing factor in )]TJ
2.175 -1.25 Td
[(cerebrovascular disease. )55 (Am Heart J 2000;140:70-6.)]TJ
ET
0 0 0 1 K
53.468 76.5 m
558.468 76.5 l
S
0 0 0 0 k
494.29 69.365 64.178 -15.665 re
f*
BT
0 0 0 1 k
/T1_2 1 Tf
0 Tc 0 Tw 8 0 0 8 549.468 56.4344 Tm
(57)Tj
ET
0 0 0 0 k
53.021 70.874 203 -17.272 re
f*
BT
0 0 0 1 k
/T1_2 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.0209 56.336 Tm
[(Nietert, et al: Depr)37 (ession in SSc)]TJ
ET
0 0 0 0 k
/GS0 gs
104.631 81.583 407.5 -10.833 re
f*
0.5 w
/GS1 gs
104.631 81.583 407.5 -10.833 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
ET
/GS2 gs
BT
/T1_3 8 Tf
106.328 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS3 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS3 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS3 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
55 0 obj
<>stream
8;Z\6>EZlX#kS!JaE;[[=@,"B&NAsp:7:KE-RBTTO>6Xc5I*&O_nfZ/YAa*!qUE[E
M=8b&`55B"MQ*o*pV73HN%bM(V,;`QZT\-de4OA6e0\2
8"DL?41);T`ca[g3aL0^
@OZMU!d#lN%qs8]>doYGl6_grl<6$&oRVtnfNFIc;!AUY":IjNhDX&0=0]Nn$Df@R
/gB^F$+W#K-e06cafU@?W\rS(d\R8&_5Zo?>U\Ui%S@_8X6o"*oc)pD.i;GT9.fk/
Yi<.oKAM'/iFbpi?e8h)41KH\8hnJY>Gg37H/IrO1'JtDcJK9N)WuLX[l@M.KYduS
!FE\CXWa6p,ade$jKlks=^7Uk1c,#sckd,Lo2MY`&1cV=bb7?K[r9jm^`7+I*HnT+
S/+#C`GV!Kgtu)EJsW`5H9FFr6(+PX:WcTD>=0%'Kfh=aW:]5nBk56ls*>HQ
+i@Wi15NKN2XOGilS>m*5lN&!:#b;e30ZkFW'l9k@N6I'NjU%"@,i+[1qC\2[K3&@
0p7D[=aK+<,OQO=8?k3pW[ZcCZ5QH1@P,jn"C)5r>`U7ab^CdWag546i<%l*;20i9
j7CWea\e\%"`Qg!i,U>('>AmP[Nk
endstream
endobj
59 0 obj
[/Indexed/DeviceRGB 255 58 0 R]
endobj
58 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
90 0 obj
<>
endobj
35 0 obj
<>
endobj
78 0 obj
<>
endobj
114 0 obj
<>
endobj
191 0 obj
<>
endobj
79 0 obj
<>
endobj
105 0 obj
<>stream
HiPSYBey&ݺԈHKe""[7"K@BXB B *8J]0c:3=T=/]3Q[u9O]pw+xU!_f46Y.18Ċ 3Q1Uǚ8-HңWYهȱa®ݭ#q]r:(U&$&I6mt}DoK2/;SET8VOd}%|q%ƴ@BRql_+>J)",OoAǦ$iO'$b?ܾ},XavX'#þHjF`$U`#5~oʳFZb:z#l\`[mږ؎S84u&.l]uрfZ _PN{,X<<\
4?np#iՖՒSԦnuv7K2zʐ]Pˊ| qsLķ5/5>sM|.گLGˑ-X윗/<3